Agranulocyosis in Beta Thalassemia Major Patients treated with Oral Iron Chelating Agent (Deferiprone)

نتاج البحث: المساهمة في مجلةمراجعة النظراء

12 اقتباسات (Scopus)
4 التنزيلات (Pure)


Deferiprone is an oral chelating agent that has been recently shown to reduce cardiac siderosis, but is also known to be associated with serious side effects like agranulocytosis which can be fatal. This report is a single centre experience of 5 cases with severe agranulocytosis in amongst 144 patients (3.47%) of thalassemia major on combined chelation therapy with subcutaneous desferrioxamine and oral deferiprone which is much higher than the previous reports.

اللغة الأصليةEnglish
الصفحات (من إلى)275-277
عدد الصفحات3
دوريةOman Medical Journal
مستوى الصوت23
رقم الإصدار4
حالة النشرPublished - أكتوبر 2008

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700???

قم بذكر هذا